Biokinetics and effects of barium sulfate nanoparticles

Abstract

BackgroundNanoparticulate barium sulfate has potential novel applications and wide use in the polymer and paint industries. A short-term inhalation study on barium sulfate nanoparticles (BaSO4 NPs) was previously published [Part Fibre Toxicol 11:16, 2014]. We performed comprehensive biokinetic studies of 131BaSO4 NPs administered via different routes and of acute and subchronic pulmonary responses to instilled or inhaled BaSO4 in rats.MethodsWe compared the tissue distribution of 131Ba over 28 days after intratracheal (IT) instillation, and over 7 days after gavage and intravenous (IV) injection of 131BaSO4. Rats were exposed to 50 mg/m3 BaSO4 aerosol for 4 or 13 weeks (6 h/day, 5 consecutive days/week), and then gross and histopathologic, blood and bronchoalveolar lavage (BAL) fluid analyses were performed. BAL fluid from instilled rats was also analyzed.ResultsInhaled BaSO4 NPs showed no toxicity after 4-week exposure, but a slight neutrophil increase in BAL after 13-week exposure was observed. Lung burden of inhaled BaSO4 NPs after 4-week exposure (0.84 ± 0.18 mg/lung) decreased by 95% over 34 days. Instilled BaSO4 NPs caused dose-dependent inflammatory responses in the lungs. Instilled BaSO4 NPs (0.28 mg/lung) was cleared with a half-life of ≈ 9.6 days. Translocated 131Ba from the lungs was predominantly found in the bone (29%). Only 0.15% of gavaged dose was detected in all organs at 7 days. IV-injected 131BaSO4 NPs were predominantly localized in the liver, spleen, lungs and bone at 2 hours, but redistributed from the liver to bone over time. Fecal excretion was the dominant elimination pathway for all three routes of exposure.ConclusionsPulmonary exposure to instilled BaSO4 NPs caused dose-dependent lung injury and inflammation. Four-week and 13-week inhalation exposures to a high concentration (50 mg/m3) of BaSO4 NPs elicited minimal pulmonary response and no systemic effects. Instilled and inhaled BaSO4 NPs were cleared quickly yet resulted in higher tissue retention than when ingested. Particle dissolution is a likely mechanism. Injected BaSO4 NPs localized in the reticuloendothelial organs and redistributed to the bone over time. BaSO4 NP exhibited lower toxicity and biopersistence in the lungs compared to other poorly soluble NPs such as CeO2 and TiO2.Electronic supplementary materialThe online version of this article (doi:10.1186/s12989-014-0055-3) contains supplementary material, which is available to authorized users.

Transfer studies of polystyrene nanoparticles in theex vivohuman placenta perfusion model: key sources of artifacts

“…For soluble NPs such as various metal oxides, it is important to understand particle dissolution to be able to distinguish between uptake and/or translocation of NPs, particle fragments or dissolved ions. A recent NP translocation study in rats demonstrated that it is of key relevance to perform such NP dissolution studies under in vivo -like conditions [24]. In this work, the fast clearance of inhaled BaSO 4 NPs did not correlate with its very low dissolution rate in phagolysosomal simulant fluid (PSF) [24], a proposed model of macrophage dissolution/clearance of particles.…”

“…A recent NP translocation study in rats demonstrated that it is of key relevance to perform such NP dissolution studies under in vivo -like conditions [24]. In this work, the fast clearance of inhaled BaSO 4 NPs did not correlate with its very low dissolution rate in phagolysosomal simulant fluid (PSF) [24], a proposed model of macrophage dissolution/clearance of particles. The authors conclude that the currently used cell-free in vitro dissolution studies either lack crucial constituents or do not adequately simulate the processes that facilitate particle dissolution and increase bioavailability.…”

Lung particle overload: old school –new insights?

“…Morfeld et al [16] concurred with the conclusion of the authors that particle surface area rather than volume or mass was the appropriate metric to confirm that both particle types are PSP particles; whereas Pauluhn [18] pointed to an enhanced dissolution of BaSO 4 when fitting the data of the accumulation phase. Indeed a recent study [20] in rats with inhalation and intratracheal instillation of nano-sized BaSO 4 reported that 95% of the retained lung burden of BaSO 4 was cleared within 34 days post-inhalation and that the retention halftime of instilled BaSO 4 was less than 10 days. This is significantly faster than a normal T½ of 60–80 days for both modes of BaSO 4 delivery to the lung.…”

In vitro apoptotic and DNA damaging potential of nanobarium oxide

“…17 Experimental evidence has shown that barium sulfate nanoparticles cause lung injury and inflammation in rats. 18 During oxidative stress, the antioxidant mechanisms are Oberdorster et al 19 reported that the reduction of GSH and stimulation of LPO and ROS induce oxidative damage of cell components. ROS, lipid peroxidation, and SOD activity was increased, whereas glutathione level was less in BaONPs-treated L929 cells.…”